BARDA funds would def come in handy... the first linked to post below relays which Rxs are currently benefiting from such funding.
PYMX leveraged subs govt funds in early stages. and right now Richard Scott, at Fox Chase, is researching the gram-neg def-mim compounds with fed $.
obama's ABX-spec budget would also free up more moolah for NIH and like agencies. but of course getting a Big Rx partner/deal would really open up the funding floodgates to adv the ABX pipeline.
News 
Market Data 
Discover 
